• Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
23 /Dec

AmoyDx Collaborates with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for China Market

Xiamen, China, December 23, 2020 (12:30 pm) – Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that it signed an agreement with Merck KGaA, Darmstadt, Germany, to develop a Companion Diagnostic (CDx) test supporting the novel MET inhibitor tepo

16 /Nov

AmoyDx Signs Memorandum with AstraZeneca to Cooperate in Molecular Diagnostics in Gynecological Oncology worldwide

Xiamen, China, 16th November, 2020 – Recently Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) signed a collaborative memorandum with AstraZeneca in the third China International Import Expo.

14 /Nov

Visit AmoyDx at 2020 AMP Virtual Meeting & Expo

The 2020 AMP Virtual Meeting & Expo starts MONDAY and we cannot wait to meet you online. If you do not want to miss the great content shared from AmoyDx, be sure to stop by our virtual booth during November 16th - 20th.

04 /Sep

AmoyDx EGFR Detection Method Won the 21st China's Top Patent Award

The EGFR mutation detection method from AmoyDx (Application No.: ZL200910111499.2, Publication No.: CN101608240B) won the Silver Award of the 21st China Patent Award as recently announced by the China National Intellectual Property Administration (CNIPA).

more

New Products

new product release

    New Products

    new product release
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

    • HANDLE Classic NGS Panel

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR Pan Lung Cancer PCR Panel
      02
    • NGS HRD Focus Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
  1. NGS
  2. PCR
  3. FISH
  4. Extraction

World Conference on Lung Cancer 2020

https://wclc2020.iaslc.org/

January 26 – 29, 2021
meet us

AMP Annual(Association for Molecular Pathology) 2020

https://amp20.amp.org/

November 19-21, 2020
  • Stock Info

    Stock info
  • 79.800 +2.31 +2.98%
    Stock code:300685 2021-01-18 15:35:00 Real-time data
  • View details
Inquiry
* Required information
Manage your account info
Change your password